Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Urogynecology Journal
Published in: International Urogynecology Journal 4/2016

01-04-2016 | Clinical Opinion

Managing novel orally administered anticoagulants in patients undergoing urogynaecological surgery

Authors: Claire M. McCarthy, Orfhlaith E. O’Sullivan, Barry A. O’Reilly

Published in: International Urogynecology Journal | Issue 4/2016

Login to get access

Abstract

The use of novel orally administered anticoagulant agents (NOACs) provides new challenges to clinicians in the perioperative care of patients undergoing urogynaecological surgery. We aimed to assess evidence for managing patients taking NOACs before and after urogynaecological surgery. We conducted a literature search in CINAHL, MEDLINE, CENTRAL, Cochrane Library and PubMed for original research articles in the English language on this topic. However, despite initially identifying 556 articles, no articles pertained to the use of NOACs in urogynaecological surgery. We subsequently reviewed national and international guidance on managing patients prescribed NOACs and created a concise guideline to aid urogynaecologists in the perioperative care of these patients. Consensus is needed on perioperative optimisation of anticoagulation in urogynaecological patients using NOACs.
Literature
1.
Ault ML, Cooper SJ, Peruzzi WT (1997) The preoperative assessment clinic: its value and function. Anesthesiol Clin North America 15(4):735–752CrossRef
2.
3.
Antovic B (2013) Essential guide to blood coagulation, 2nd edn. Wiley-Blackwell, LondonCrossRef
4.
5.
Bayer Healthcare (2015) Rivaroxaban (Xarelto) Prescribing Information
6.
7.
Glund S, Stangier J, Schmohl M et al (2013) A specific antidote for dabigatran: immediate, complete and sustained reversal of dabigatran induced anticoagulation in healthy male volunteers. American Heart Association Scientific Sessions, Dallas, Abstract 17765
8.
Mohanty, Looser P, Gokanapudy L et al (2014) Controversies regarding the new oral anticoagulants for stroke prevention in patients with atrial fibrillation. Vasc Med 19:3190–3204
9.
Forster K, Ebertz F, Gelbricht V et al (2013) Pattern and Management of Bleeding Complications with Novel Oral Anticoagulants – Results of the Prospective Dresden Noac Registry. Presented as an Oral Presentation at the 55th Annual Meeting and Exposition, New Orleans, LA, 10 Dec 2013
10.
Giugliano RP, Ruff CT, Wiviott SD et al (2014) Reduction in bleeding with edoxaban vs warfarin linked to lower all-cause mortality in 21,105 patients randomized in the ENGAGE AF-TIMI 48 trial. European Society of Cardiology Congress, Barcelona
11.
Irish Centre of Hereditary Coagulation Disorders (2014) Management of bleeding or surgery. Saint James’ Hospital, Dublin
12.
Comprehensive Coagulation Centre (2014) Preprocedural management of patients on dabigatran or rivaroxaban. Cork University Hospital, Cork
13.
Makris M, Van Veen JJ, Tait CR et al (2012) Guideline on the management of bleeding in patients on antithrombotic agents. Br J Haematol 160:35–46
14.
Tran H, Joseph J, Young L et al (2014) New oral anticoagulants: a practical guide on prescription, laboratory testing and periprocedural/bleeding management. Intern Med J 44:525–536
15.
Cashman, Lim, Zakai (2014) Clinical Practice Guide on Antithrombotic Drug Dosing and Management of Anti-thrombotic drug associated bleeding complications. Presented by the American Society of Hematology, adapted in part from the American College of Chest Physicians Evidence-Based Clinical Practice Guideline on Antithrombotic and Thrombolytic Therapy (9th Edition)
16.
Thrombosis Canada (2015) New/Novel Oral Anti-coagulants (NOACS): Preoperative Management.
17.
Heidbuchel H, Verhamme P, Alings M et al (2013) European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Eur Heart J 34:791–795
18.
Garry R, Fountain J, Mason S et al (2004) The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy; the other comparing laparoscopic with vaginal hysterectomy. BMJ 328(7432):129
19.
Nguyen JN, Burchette RJ (2008) Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynaecol 111:891–898CrossRef
20.
Istre O (2009) Managing bleeding, fluid absorption and uterine perforation at hysteroscopy. Clin Obstet Gynecol 23(5):619–629
21.
Thiagamoorthy G, Khalil A, Cardozo L et al (2014) The value of vaginal packing in pelvic floor surgery: a randomised double-blind study. Int Urogynecol J 25(5):585–591. doi:10.​1007/​s00192-013-2264-y
22.
Falagas ME, Athanasiou S, Iavazzo C et al (2008) Urinary tract infections after pelvic floor gynaecological surgery: prevalence and effect of antimicrobial prophylaxis. A systematic review. Int Urogynecol J 19(8):1165
23.
Makinen J, Johansson J, Tomas C et al (2001) Morbidity of 10 110 hysterectomies by type of approach. Hum Repro 16(7):1473–1478CrossRef
24.
Falagas ME, Velakoulis S, Iavazzo C, Athanasiou S (2007) Mesh-related infections after pelvic organ prolapse repair surgery. Eur J Obstet Gynaecol Reprod Biol 134:147–56CrossRef
25.
O’Sullivan OE, O’Reilly BA (2012) Robot-assisted surgery:—impact on gynaecological and pelvic floor reconstructive surgery. Int Urogynecol J 23(9):1163–1173CrossRefPubMed
Metadata
Title
Managing novel orally administered anticoagulants in patients undergoing urogynaecological surgery
Authors
Claire M. McCarthy
Orfhlaith E. O’Sullivan
Barry A. O’Reilly
Publication date
01-04-2016
Publisher
Springer London
Published in
International Urogynecology Journal / Issue 4/2016
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-015-2931-2

Other articles of this Issue 4/2016

International Urogynecology Journal 4/2016 Go to the issue

Review Article

Pelvic floor symptoms in female cyclists and possible remedies: a narrative review

IUJ Video

Technique of extraperitoneal uterosacral ligament suspension for apical suspension

Review Article

Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis

Original Article

Elastin density: Link between histological and biomechanical properties of vaginal tissue in women with pelvic organ prolapse?

Original Article

Effects of a new community-based reproductive health intervention on knowledge of and attitudes and behaviors toward stress urinary incontinence among young women in Shanghai: a cluster-randomized controlled trial

Editorial

Patient reported outcome measures after incontinence and prolapse surgery: are the pictures painted by the ICIQ and PGI-I accurate?